The Female Health Company (FHCO)
-NasdaqCM | Prev Close: | 8.86 |
|---|
| Open: | N/A |
|---|
| Bid: | 8.82 x 500 |
|---|
| Ask: | 9.49 x 100 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | 0.91 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 5.25 - 8.39 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 98,144 |
|---|
| Market Cap: | 253.76M |
|---|
| P/E (ttm): | 14.50 |
|---|
| EPS (ttm): | 0.61 |
|---|
| Div & Yield: | 0.28 (3.20%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- FEMALE HEALTH CO Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial StateEDGAR Online(Wed, May 22)
- Growth Stocks Portfolio That Can Outperform The Market By A Big Marginat Seeking Alpha(Mon, May 20)
- The Female Health Company To Present At 14th Annual B. Riley & Co. Investor Conference On May 20, 2013PR Newswire(Wed, May 15)
- Andrew Love Joins The Female Health Company Board of DirectorsPR Newswire(Tue, May 14)
- FEMALE HEALTH CO Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or BylEDGAR Online(Tue, May 14)
- FEMALE HEALTH CO FinancialsEDGAR Online Financials(Fri, May 10)
- The Female Health Company's CEO Discusses F2Q13 Results - Earnings Call Transcriptat Seeking Alpha(Thu, May 2)
- The Female Health Company Reports 21% Rise in Net Revenues and 55% Increase in Operating Income for Second Quarter of FY2013PR Newswire(Thu, May 2)
- Q2 2013 Female Health Co Earnings Release - Before Market OpenCCBN(Thu, May 2)
- FEMALE HEALTH CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Thu, May 2)
- The Condom War Is Heating Upat Motley Fool(Mon, Apr 29)
- Cash Dividend On The Way From Female Health (FHCO)at TheStreet(Thu, Apr 25)
- The Female Health Company To Report Second Quarter Operating Results on Thursday, May 2, 2013PR Newswire(Thu, Apr 25)
- An Investment Opportunity for a Healthy Worldat Motley Fool(Fri, Apr 19)
- Why Female Health Is Poised to Outperformat Motley Fool(Tue, Apr 2)
Key Statistics
| Forward P/E (1 yr): | 13.22 |
|---|
| P/S (ttm): | 6.69 |
|---|
| Ex-Dividend Date: | 29-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | 0.52 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.12 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
The Female Health Company engages in the development, manufacture, marketing, and sale of consumer health care products. It offers the FC2 female condom that provides dual protection against unintended pregnancy and sexually transmitted infections...
View More 
0.08%